OVULIS HEALTHTECH PRIVATE LIMITED converges lab-grade multiplex microfluidic sensors with clinical-grade time-series neural models. We empower fertility clinics, healthcare systems, and individuals with quantified hormonal tracking and predictive ovulation windows.
Active Biomarker Telemetry
Founded at the intersection of molecular biotechnology and artificial intelligence, OVULIS HEALTHTECH PRIVATE LIMITED is engineered by reproductive endocrinologists, microfluidic engineers, and machine learning researchers. We decode complex hormone dynamics into actionable diagnostic insights for women and clinical specialists worldwide.
To demystify reproductive endocrinology by transitioning laboratory-grade testing into accessible, continuous, and non-invasive digital health solutions that reduce reproductive anxiety.
To establish the global benchmark in FemTech clinical intelligence, creating an interoperable continuum across preconception, IVF support, PCOS care, and perimenopause navigation.
We invest over 35% of capital expenditure into foundational biomedical research, nanobiosensor surface functionalization, and multimodal reproductive transformer models.
By combining microfluidic biochemical binding kinetics with longitudinal machine learning, OVULIS eliminates the guesswork of qualitative urine strips and non-specific wearables.
Patented nano-capillary test chips capable of simultaneously quantifying salivary and urinary Luteinizing Hormone (LH), Estradiol (E2), and Progesterone metabolite (PdG) with a coefficient of variation (CV) under 4.8%.
CycleAI™ uses temporal convolutional networks and self-attention transformers to map individual hormonal baselines, adjusting dynamic thresholds for women with irregular cycles, anovulatory episodes, or PCOS phenotypes.
Cloud architecture natively streams compliant structured clinical observations into major Hospital Electronic Medical Records (EMR/EHR), facilitating seamless IVF cycle management and clinical trial tracking.
From home biomarker testing to institutional IVF workflow management, OVULIS provides an integrated hardware-software ecosystem.
Pocket-sized optical and bio-impedance reader delivering quantitative concentration levels of LH, E2, and PdG in under three minutes with high analytical sensitivity.
Our proprietary neural inference engine trained on 1.2M+ validated hormonal cycles. Accurately anticipates the LH surge 24–48 hours ahead of conventional strips.
Enterprise clinical portal designed for IVF and fertility physicians. Monitors home stimulation cycles, tracks follicle synchronization, and coordinates trigger shot timings.
Patient-centric mobile app providing clear hormonal trajectory charts, reproductive health guidance, encrypted record vaults, and seamless specialist telehealth consults.
Adjust the physiological phenotype and timeline slider to inspect multi-analyte hormonal concentrations (LH, E2, PdG) and real-time algorithmic classification.
* Numerical curves generated by OVULIS Endocrine Kinetic Differential Model. Validated for academic demonstration.
At OVULIS HEALTHTECH PRIVATE LIMITED, our products undergo rigorous peer-reviewed clinical trials and analytical performance evaluations against gold-standard hospital chemiluminescence immunoassay analyzers (CLIA).
Audited quality management encompassing design control, sensor fabrication cleanroom standards, software life-cycle (IEC 62304), and post-market surveillance.
AES-256 at-rest hardware encryption, zero-knowledge architectural partitions, and anonymized de-identification protect sensitive reproductive biological data.
Conducted across tertiary reproductive endocrinology centers covering 1,200+ prospective cycles with serial transvaginal ultrasound (TVUS) correlation.
Class IIa Software as a Medical Device (SaMD) documentation compiled for notified body submission.
Effortless bidirectional integration into Epic, Cerner, and specialty fertility clinic EMR platforms.
Proprietary IP portfolio protecting microfluidic fluid flow mechanisms, immunoassay strips, and neural algorithms.
Honored with the Global Digital Health Innovation Award for Breakthrough Women's Health Technology.
INSTITUTIONAL COLLABORATORS & RESEARCH AFFILIATIONS
Whether you represent an assisted reproductive technology (ART) clinic, an institutional healthcare network, an academic research group, or a specialized healthcare investment fund, our executive team is ready to connect.